Business
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performanc...
About this update from Discovery Harbour Resources Corp.
[{"type":"text","content":"\n \n \n \n Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint:\n \n \n \n Up To 215 Tests/Hour/Square Meter\n \n \n \n \n Innovations Bolster Assay Performance and Laboratory Productivity with\n \n \n \n New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time System Monitoring, and is the\n \n Only Immunoassay Analyzer with No Daily Maintenance\n \n \n i\n \n \n \n \n \n \n \n NT-proBNP Assay Now Available with Age-Based Cutoffs and Comorbidity Data\n \n \n \n \n \n ROME\n \n \n ,\n \n \n May 15, 2023\n \n \n /CNW/ -- Beckman Coulter, a clinical diagnostics leader, today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m\n \n 2\n \n ).\n \n \n \n \n \n \n \n \n \n The DxI 9000 Analyzer innovations address today's speed, reliability, reproducibility, quality, and menu expansion demands. The platform has been independently verified to perform at the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) optimal level, the highest level of EFLM performance evaluation.  At the same time, the novel Lumi-Phos PRO Substrate has shown the capability to develop increasingly sensitive and clinically relevant assays, ensuring the system is able to meet the healthcare needs of tomorrow.\n \n \n According to\n \n Julie Sawyer Montgomery\n \n , President, Beckman Coulter Diagnostics, \"The DxI 9000 Access Immunoassay Analyzer sets new expectations for immunoassay testing operational performance and ability to develop and sustain improved assay sensitivity to meet tomorrow's analytical needs. Those in the laboratory will treasure ZeroDaily Maintenance to save them time, PrecisionVision Technology...